Manager × security

Bullseye Asset Management LLC TMDX holdings history

Who else holds this security? →

TRANSMEDICS GROUP INC · CUSIP 89377M109 · CIK 1513779

Some filings reported values in thousands; those figures were scaled ×1000 to dollars.
This is the oldest quarter open without an account, so changes against the quarter before it are withheld. Sign in to see them.
Citable facts

As of 2026-06-30, Bullseye Asset Management LLC reported 24.30K TMDX (shares), valued at $1.61M, or 0.82% of its reported non-derivative portfolio. Filed 2026-08-12.

Verify history & sources →
Portfolio weight and quantity history
Reported portfolio weight
0.82%
Shares
24.30K
24,301
Reported value
$1.61M
USD

Shares increased 1.00%; reported value decreased 32.53%, and weight changed -0.57 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.

Left: % · Right: Shares · Independently scaled axes

Exact data and methodology

Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.

QuarterWeightQuantitySource
Q2 20260.82%24,301SEC filing ↗Filed Aug 12, 2026
Q1 20261.39%24,061SEC filing ↗Filed May 14, 2026
Q4 20251.58%24,061SEC filing ↗Filed Feb 13, 2026
Q3 20251.41%24,061SEC filing ↗Filed Nov 13, 2025
Q2 20251.61%24,061SEC filing ↗Filed Aug 12, 2025
Q1 20251.74%47,754SEC filing ↗Filed May 14, 2025
Q4 20241.40%47,754SEC filing ↗Filed Feb 14, 2025
Q3 20242.62%36,201SEC filing ↗Filed Nov 15, 2024
Q2 20243.61%49,000SEC filing ↗Filed Aug 15, 2024
Q1 20242.45%70,512SEC filing ↗Filed May 14, 2024
Q4 20232.66%70,512SEC filing ↗Filed Feb 13, 2024

History & evidence by quarter

QuarterWeightQuantityValueChange explainedSource
Q4 20232.66%70,512$5.57MThe prior quarter is outside the free window. Sign in for the comparison.SEC filing ↗
Filed Feb 13, 2024
Q1 20242.45%70,512$5.21MShares unchanged; reported value decreased 6.31%, and weight changed -0.21 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 14, 2024
Q2 20243.61%49,000$7.38MShares decreased 30.51%; reported value increased 41.54%, and weight changed +1.16 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 15, 2024
Q3 20242.62%36,201$5.68MShares decreased 26.12%; reported value decreased 22.98%, and weight changed -0.99 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 15, 2024
Q4 20241.40%47,754$2.98MShares increased 31.91%; reported value decreased 47.62%, and weight changed -1.22 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 14, 2025
Q1 20251.74%47,754$3.21MShares unchanged; reported value increased 7.93%, and weight changed +0.34 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 14, 2025
Q2 20251.61%24,061$3.23MShares decreased 49.61%; reported value increased 0.37%, and weight changed -0.13 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 12, 2025
Q3 20251.41%24,061$2.70MShares unchanged; reported value decreased 16.28%, and weight changed -0.20 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 13, 2025
Q4 20251.58%24,061$2.93MShares unchanged; reported value increased 8.41%, and weight changed +0.17 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 13, 2026
Q1 20261.39%24,061$2.39MShares unchanged; reported value decreased 18.28%, and weight changed -0.19 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 14, 2026
Q2 20260.82%24,301$1.61MShares increased 1.00%; reported value decreased 32.53%, and weight changed -0.57 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 12, 2026
Bullseye Asset Management LLC · TRANSMEDICS GROUP INC

Take these holdings further.

This page includes 11 of 11 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.

  • Download CSV
  • Earlier quarters
  • Advanced screening & filtering
  • API & AI access
Already have an account?

+ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.

MCP  https://api.akkrudata.ai/mcp

get_institutional_portfolio
{"cik":"1513779","quarter":"2026Q2","cusip":"89377M109"}

get_institutional_manager_history
{"cik":"1513779","page_size":100}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint
https://api.akkrudata.ai/mcp
API / MCP documentation
/documents
llms.txt
/llms.txt
Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

13F reports quarter-end long positions in securities traded on US exchanges, filed by managers holding at least $100 million of such securities; it is not the manager's full portfolio, not assets under management, and value changes are not returns. Weights use the reported total value as denominator. Option rows show notional value, not premium or net exposure. Amendments are merged into the quarter when Akkru could match them.